Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 16 08 2020
accepted: 30 03 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 29 6 2021
Statut: epublish

Résumé

Replication competent vesicular stomatitis virus (VSV) is the basis of a vaccine against Ebola and VSV strains are developed as oncolytic viruses. Both functions depend on the ability of VSV to induce adequate amounts of interferon-α/β. It is therefore important to understand how VSV triggers interferon responses. VSV activates innate immunity

Identifiants

pubmed: 33995343
doi: 10.3389/fimmu.2021.595390
pmc: PMC8119886
doi:

Substances chimiques

RNA, Viral 0
Receptors, Immunologic 0
RIGI protein, human EC 3.6.1.-
DEAD Box Protein 58 EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

595390

Informations de copyright

Copyright © 2021 Linder, Bothe, Linder, Schwarzlmueller, Dahlström, Bartenhagen, Dugas, Pandey, Thorn-Seshold, Boehmer, Koenig, Kobold, Schnurr, Raedler, Spielmann, Karimzadeh, Schmidt, Endres and Rothenfusser.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS Pathog. 2012;8(8):e1002839
pubmed: 22912574
Dev Cell. 2015 Dec 21;35(6):698-712
pubmed: 26702829
J Gen Virol. 2017 Dec;98(12):2895-2911
pubmed: 29143726
J Mol Biol. 1975 Sep 25;97(3):289-307
pubmed: 171415
Science. 2006 Nov 10;314(5801):994-7
pubmed: 17038590
J Virol. 2004 Oct;78(19):10636-49
pubmed: 15367631
Future Virol. 2018 Jul;13(7):493-503
pubmed: 30245734
J Virol. 2008 Dec;82(24):12104-15
pubmed: 18829743
J Virol. 2003 Apr;77(8):4646-57
pubmed: 12663771
J Gen Virol. 2012 Dec;93(Pt 12):2529-2545
pubmed: 23052398
Genome Res. 2014 Oct;24(10):1719-23
pubmed: 25186908
PLoS Pathog. 2015 Sep 03;11(9):e1005122
pubmed: 26336095
Immunity. 2009 Jul 17;31(1):25-34
pubmed: 19576794
Mol Biol Rep. 2019 Jun;46(3):3371-3379
pubmed: 31006094
Lancet. 2017 Feb 4;389(10068):505-518
pubmed: 28017403
Hum Gene Ther. 2008 Jun;19(6):635-47
pubmed: 18533893
Methods Mol Biol. 2014;1169:37-44
pubmed: 24957227
J Virol. 2015 Aug;89(15):7735-47
pubmed: 25972541
mBio. 2019 May 28;10(3):
pubmed: 31138743
J Virol. 2010 Feb;84(3):1563-73
pubmed: 19906910
Semin Immunol. 2018 Oct;39:65-72
pubmed: 30041831
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12067-72
pubmed: 19574455
J Virol. 1984 Aug;51(2):515-21
pubmed: 6086960
Cell Host Microbe. 2013 Mar 13;13(3):336-46
pubmed: 23498958
Virology. 2015 May;479-480:110-21
pubmed: 25749629
PLoS Pathog. 2014 Apr 17;10(4):e1004081
pubmed: 24743923
Curr Top Microbiol Immunol. 1981;93:151-207
pubmed: 7026180
Nature. 2008 Jul 24;454(7203):523-7
pubmed: 18548002
Cell. 1981 Feb;23(2):477-84
pubmed: 6258804
Mol Cell. 2000 Nov;6(5):1243-52
pubmed: 11106761
Immunol Rev. 2011 Sep;243(1):91-8
pubmed: 21884169
J Virol. 1984 Feb;49(2):303-9
pubmed: 6319730
J Virol. 2006 Mar;80(5):2194-205
pubmed: 16474127
Cell. 1981 Oct;26(2 Pt 2):145-54
pubmed: 7037195
J Virol. 2013 May;87(9):4798-807
pubmed: 23449801
Mol Cell. 2015 May 7;58(3):541-548
pubmed: 25891073
Nature. 2014 Oct 16;514(7522):372-375
pubmed: 25119032
J Interferon Cytokine Res. 2009 Sep;29(9):499-509
pubmed: 19715459
Cancer Res. 2003 Jul 1;63(13):3605-11
pubmed: 12839948
PLoS One. 2007 Mar 14;2(3):e279
pubmed: 17356690
J Clin Invest. 2009 Aug;119(8):2399-411
pubmed: 19620789
Science. 2006 Nov 10;314(5801):997-1001
pubmed: 17038589
Front Microbiol. 2019 Aug 09;10:1852
pubmed: 31447826
J Virol. 1981 Feb;37(2):661-72
pubmed: 6261012
J Gen Virol. 2012 Feb;93(Pt 2):299-307
pubmed: 22049094
Proc Natl Acad Sci U S A. 1982 Sep;79(17):5240-4
pubmed: 6291035
Cold Spring Harb Symp Quant Biol. 1987;52:367-71
pubmed: 2841068
Nature. 2006 May 4;441(7089):101-5
pubmed: 16625202
Leukemia. 2020 Apr;34(4):1017-1026
pubmed: 31740809
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4477-81
pubmed: 7753828
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16303-8
pubmed: 20805493
Glia. 2010 Oct;58(13):1620-9
pubmed: 20578054
Biochemistry. 1976 Apr 20;15(8):1663-7
pubmed: 178352
Microbiol Mol Biol Rev. 2011 Sep;75(3):468-90, second page of table of contents
pubmed: 21885681
Biomedicines. 2017 Feb 10;5(1):
pubmed: 28536351

Auteurs

Andreas Linder (A)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.

Viktoria Bothe (V)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Nicolas Linder (N)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Paul Schwarzlmueller (P)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Frank Dahlström (F)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Christoph Bartenhagen (C)

Institute of Medical Informatics, University of Münster, Münster, Germany.

Martin Dugas (M)

Institute of Medical Informatics, University of Münster, Münster, Germany.

Dharmendra Pandey (D)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Julia Thorn-Seshold (J)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.

Daniel F R Boehmer (DFR)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Lars M Koenig (LM)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Sebastian Kobold (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany.

Max Schnurr (M)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Johannes Raedler (J)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Giulia Spielmann (G)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Hadi Karimzadeh (H)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.

Andreas Schmidt (A)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.

Stefan Endres (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.

Simon Rothenfusser (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH